Human Reproduction, Vol. 16, No. 9, 1989-1994,
September 2001
© 2001 European Society of Human Reproduction and Embryology
Value of magnetic resonance imaging in predicting efficacy of GnRH analogue treatment for uterine leiomyoma
1 Departments of Obstetrics and Gynecology and 2 Radiology, Shimane Medical University, Izumo, Shimane 693-8501, Japan, and 3 Department of Radiology, Kobe University School of Medicine, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
BACKGROUND: Estimating pharmacological efficacy is important when selecting conservative treatment of uterine leiomyoma. Hence, the ability of magnetic resonance (MR) imaging to predict gonadotrophin-releasing hormone (GnRH) analogue efficacy was investigated. METHODS: A total of 85 lesions was studied in 40 patients who were clinically diagnosed as having uterine leiomyoma and treated with GnRH analogue for 24 weeks. To evaluate changes in lesion size, T2-weighted and gadopentetate-dimeglumine (Gd-DTPA)-enhanced, T1-weighted MR images were obtained within 2 weeks before, and immediately after termination of, GnRH analogue treatment. RESULTS: An average 46.3% size reduction was observed in 45 lesions (52.9%); these were seen as low signal intensity on T2-weighted images and enhanced by Gd-DTPA. Also, an average 44.7% size reduction was observed in lesions enhanced by Gd-DTPA, irrespective of signal intensity findings on T2-weighted images. The average size reduction of unenhanced lesions was only 17.8%, and significantly different from enhanced lesions (P < 0.001). The prediction of efficacy was difficult in those lesions not enhanced. CONCLUSIONS: It is considered that evaluation of MR signal intensities, and the presence or absence of Gd-DTPA enhancement, would predict treatment efficacy before GnRH analogue administration.
Key words: contrast-enhancement/GnRH analogue/MRI/myometrium/uterine leiomyoma
4 To whom reprint requests should be addressed at: Department of Obstetrics and Gynecology, Shimane Medical University,89-1, Enya-cho, Izumo 693-8501, Japan. E-mail: taka27{at}shimane-med.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Okuda, K. Oshio, H. Shinmoto, A. Tanimoto, H. Asada, T. Fujii, Y. Yoshimura, and S. Kuribayashi Semiquantitative Assessment of MR Imaging in Prediction of Efficacy of Gonadotropin-releasing Hormone Agonist for Volume Reduction of Uterine Leiomyoma: Initial Experience Radiology, September 1, 2008; 248(3): 917 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Imaoka, A. Wada, M. Matsuo, M. Yoshida, H. Kitagaki, and K. Sugimura MR Imaging of Disorders Associated with Female Infertility: Use in Diagnosis, Treatment, and Management RadioGraphics, November 1, 2003; 23(6): 1401 - 1421. [Abstract] [Full Text] [PDF]
|
|